Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001701247-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
135,000
Total Value
$1,289,461.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Feb 17, 2026 | Exercise/Conversion | 45,000 | $2.48 | $111,600.00 | 70,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Feb 17, 2026 | Sale | 45,000 | $26.17 | $1,177,861.50 | 25,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Stock Option (right to buy) | Derivative | Feb 17, 2026 | Exercise/Conversion | 45,000 | $0.00 | $0.00 | 221,268 | Direct | โ | View Details |